Petra Tesch
Nessuna posizione attualmente
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Annette Clancy | F | 70 | 10 anni | |
| Thure Bo Thomas Thuresson | M | 67 | 6 anni | |
| Helena Ildiko Saxon | F | 54 | 13 anni | |
| Annikki Schaeferdiek | F | 55 | 7 anni | |
| Erik Johan Malmberg | M | 42 | 4 anni | |
| Jonas Johan Fredrik Hasselberg | M | 57 | 6 anni | |
| Sven Martin Vilhelm Gren | M | 62 | 7 anni | |
| Anna Maria Inga Söderblom | M | 61 | 2 anni | |
| Madeleine Samuelson | F | 52 | 2 anni | |
| Magnus Lönn | M | 50 | 2 anni | |
| Paul de Freene | M | 55 | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Wills Hughes-Wilson | F | 53 | 6 anni | |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 8 anni |
| Carl Johan Kördel | M | 62 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Jan Anders Jonas Persson | M | 52 | 22 anni | |
| Johannes G. C. P. Schikan | M | 66 | 9 anni | |
| Jason Clark | M | 51 | 2 anni | |
| Kennet Rooth | M | 69 | - | |
| Cameron McDonough | M | 53 | 6 anni | |
| Helge Martin Ödman | M | 67 | 19 anni | |
| Matthew Gantz | M | 59 | - | |
| Paul Bates | M | 49 | 12 anni | |
| Linda Alexandra Höljö | F | 52 | 3 anni | |
| Mats Gunnar Pettersson | M | 78 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Adine Charlotte Grate Axén | F | 63 | - | |
| Pia Magnhild Helena Gideon | F | 70 | - | |
| Nils Anders Hultmark | M | 70 | 13 anni | |
| Eva Maria Cecilia S. Elmstedt | F | 64 | 13 anni | |
| Asa Regen Jansson | M | 54 | 1 anni | |
| Erling Lennart Johansson | M | 69 | - | |
| Alf Gunnar Martin Nicklasson | M | 69 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 anni |
| Sara Ossborn | F | 52 | 2 anni | |
| Stephen James | M | 58 | 8 anni | |
| Birgitte Volck | M | 61 | 4 anni | |
| Rami Levin | M | 55 | - | |
| Annika Muskantor | F | 58 | 1 anni | |
| Hege Hellstrom | M | 59 | 5 anni | |
| Dennis Schmidt Pedersen | M | 54 | - | |
| Thomas Kronen | M | - | - | |
| Krassimir Mitchev | M | - | 5 anni | |
| Philip Wood | M | 56 | 9 anni | |
| Frits Wibbelink | M | - | 6 anni | |
| Kirsti Gjellan | M | 61 | 5 anni | |
| Eirik Pedersen | M | 60 | 3 anni | |
| Maarten van Unen | M | 45 | 5 anni | |
| Ann-Charlotte Arnshav | F | 56 | 2 anni | |
| Anders Petter von Essen Thulin | M | 61 | - | |
| Lars Sandström | M | 52 | 2 anni | |
| Catarina Larsson | F | 72 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 9 anni |
| Markus Thor | M | 53 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 8 anni |
| Peder Sven Walberg | M | 50 | 1 anni | |
| Åsa Stenqvist | F | 77 | - | |
| Carin Dahlquist | F | - | - | |
| Hans Glemstedt | M | 62 | 2 anni | |
| Håkan Åström | M | 77 | 9 anni | |
| Terje Kalland | M | 73 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 anni |
| Kjell Rudolf Peter Edman | M | 70 | 3 anni | |
| Paul de Potocki | M | 62 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 5 anni |
| Sven Håkan Björklund | M | 68 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Mats-Olof Ljungquist | M | 72 | 3 anni | |
| Charlotta Ljungqvist | M | 63 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Andrea Conrad | F | - | - | |
| Margit Mahlapuu | M | 52 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 2 anni |
| Jason G. Duncan | M | 50 | 1 anni | |
| Marek Poszepczynski | M | - |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 anni |
| Erik Kinnman | M | 66 | 3 anni | |
| Peter Sellei | M | 64 | 1 anni | |
| Michael Steinmetz | M | 75 | 10 anni | |
| Bo-Gunnar Rosenbrand | M | 61 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 9 anni |
| Arne Kungberg | M | 61 | 26 anni | |
| Mats-Olof Wallin | M | 73 | 5 anni | |
| Alan Henry Raffensperger | M | 64 | 5 anni | |
| Karin Möllborg | F | - | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Svezia | 73 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Petra Tesch
- Contatti personali
